<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuropsychological follow up of <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> can provide a model for evaluating the efficiency of a drug in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A double blind study has been conducted using nicardipine, a calcium-<z:chebi fb="68" ids="48706">antagonist</z:chebi>, as opposed to a placebo in 40 patients with <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo>, over a six month period </plain></SENT>
<SENT sid="2" pm="."><plain>The patients were evaluated according to a Wechsler's intelligence scale, and their memory was also tested before and after this period </plain></SENT>
<SENT sid="3" pm="."><plain>Although no alterations were registered on either scale, some differences did appear in certain sub-tests, especially as regards the verbal coefficient </plain></SENT>
<SENT sid="4" pm="."><plain>This pilot study has provided information concerning the possible beneficial effect of the drug, which should be proven by means of a larger-scale study </plain></SENT>
</text></document>